СПИСОК ЛИТЕРАТУРЫ

1. Алишева, Е. К. Методы диагностики инсулинорезистентности / Е. К. Алишева, Е. И. Красильникова, Е. В. Шляхто // Артериальная гипертензия. — 2002. — № 1. — С. 29.

2. Аметов, А.

3. Аметов, А. С. Физиология метаболизма глюкозы // Сахарный диабет 2 типа. Проблемы и решения. 2-е изд. [Глава 2], перераб. и. доп./ А.С. Аметов. — М.: ГЭОТАР-Медиа, 2013. — 17 с.

4. Баевский, Р. М. Вариабельность сердечного ритма: теоретические аспекты и возможности клинического применения // Ультразвуковая и функциональная диагностика. 2001. № 3. С. 108-127.

5. Вейн, А. М. Лекции по неврологии неспецифических систем мозга / А.М. Вейн // МЕДпресс-информ. М.: 2010. - 112 с.

6. Грибанова, О. В. Физиология пищеварительной системы / О.В. Грибанова // Ростов: Феникс, 2014. — C. 170-182.

7. Дедов, И. И. Алгоритмы специализированной медицинской помощи больным сахарным диабетом, 6-ой выпуск / под ред. И. И. Дедова, М. В. Шестакова. М.: Медицина. — 2013. — С. 6-55.

8. Држевецкая, И. А. Нейровегетативная блокада и углеводный обмен / И.

А. Држевецкая // М.: Медицина, 1973 — С. 40-51.

9. Дубровский, В. И. Физиология физического воспитания и спорта / В.И. Дубровский // М.: Владос, 2002 — С 101-104.

10. Зайчик, А. Ш. Основы общей патологии / А. Ш. Зайчик // Эффективная фармакотерапия в эндокринологии, 1999. — C. 317-345.

11. Лишманов, Ю. Б. Перфузионная сцинтиграфия миокарда / Ю. Б. Лишманов, В. И. Чернов // Радионуклидная диагностика для практических врачей. — Томск: STT, — 2004. — Гл. 2.3.1. — С. 56-94.

12. Недосугова, Л. В. Алгоритм лечения сахарного диабета 2 типа/ Л. В. Недосугова, М. И. Балаболкин — М.: Медицина, 2008. — 146 с.

13. Питерс-Хармел, Э. Сахарный диабет: диагностика и лечение/ Э.

14. Полтырев, C. C. Физиология пищеварения / C. C. Полтырев // М: Высшая школа, 1989. — С. 70-93.

15. Реброва, О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. Изд. 3-е, испр. и доп. / О. Ю. Реброва. — М.: Медиа Сфера, 2006. — С. 4-7.

16. Смирнов, В. М. Физиология человека. / В.М. Смирнов // М: Медицина, 2002. — С. 211-216.

17. Тепляков, А. Т.Оценка влияния карведилола, атенолола и их комбинации с фозиноприлом на вариабельность ритма сердца, клинико­функциональный статус и качество жизни больных с постинфарктной дисфункцией левого желудочка / А. Т. Тепляков и соавт.// Терапевтический архив. — 2004. — Т. 76, № 9. — С. 62-65.

18. Флейшман, А. Н. Вариабельность ритма сердца и медленные колебания гемодинамики: Нелинейные феномены: Учебный атлас для врачей. Новокузнецк, 2004. 99 с.

19. Хаспекова, Н. Б. Диагностическая информативность мониторирования вариабельности ритма // Вестник аритмологии. — 2003. — № 32. — С. 15-23.

20. Чазова, И. Е. Основные положения второго пересмотра рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии/ И. Е. Чазова, С. А. Бойцов, Д. В. Небиеридзе // Кардиоваск. терап. и профил. — 2004. — № 4. — С. 90-99.

21. Шилов, А. М. Клиническое значение суточного мониторирования гликемии у больных с нарушением углеводного обмена / А. М. Шилов, А. С Авшалумов, Е. Н Синицина и др. // Эффективная фармакотерапия в эндокринологии. — 2008. —№ 1. — С. 32-35.

22. Шустов, С. Б. Клиническая эндокринология / С. Б. Шустов, В. Л. Баранов,

Ю. Ш. Халимов. — М.: ООО "Издательство "Медицинское

информационное агентство", 2012. — C. 257-258.

23. Abbasi, F. Relationship between obesity, insulin resistance, and coronary heart disease risk / F. Abbasi, B. W. Jr. Brown, C. Lamendola // J. Am. Coll. Cardiol. — 2002. — Vol. 40. — P. 937-943.

24. Adziuk, J. S. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes.

25. Aeschbach, D. A longer biological night in long sleepers than in short sleepers. / D. Aeschbach et al. // J. Clin. Endocrinol. Metab. — 2003. — Vol. 88, N 1. — P. 26-30.

26. Aeschbach, D. Use of transdermal melatonin delivery to improve sleep maintenance during daytime. / D. Aeschbach et al. // Clinical Pharmacology & Therapeutics. — 2009. — Vol. 86. — P. 378-382.

27. Alva, M.L. Impact of diabetes-related complications on healthcare costs: new results from the UK Prospective Diabetes Study. / M. L. Alva et al. // Diabet. Med. — 2014. — Vol. 10. — P. 12647.

28. American Diabetes Association, Professional Practice Committee. American Diabetes Association clinical practice recommendations 2013. / American Diabetes Association // Diabetes Care — 2013. — Vol. 36, N 1. — P. 1-110.

29. American Diabetes Association, Standards of medical care in diabetes-2012. / American Diabetes Association // Diabetes Care — 2012. — Vol. 35, N 1. — P. 11-63.

30. Bass, J. Circadian integration of metabolism and energetic / J. Bass, S. Takahashi // Science. — 2010. — Vol. 330, N 6009. — P. 1349-1354.

31. Basu, R. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic

insulin extraction. / R. Basu et al. // Diabetes. — 2006. — Vol. 55. — P. 2001­2014.

32. Berne, C. The sympathetic response to euglycaemic hyperinsulinaemia: the evidence from microelectrode nerve recordings in healthy subjects. / C. Berne et al. // Diabetologia. — 1992. — Vol. 35. — P. 873-879.

33. Bhardwaj, S. Variations in 7-day/24-h circadian pattern of ambulatory blood pressure and heart rate of type 2 diabetes patients / S. Bhardwaj et al // J. Diabetes Investig. — 2014. — Vol. 5, N 6. — P. 728-733.

34. Bisschop, P. H. Autonomic regulation of hepatic glucose production / P. H Bisschop, A.

35. Boden, G. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. / G. Boden et al. // Diabetes. — 2006. — Vol.50, N 4. — P. 810-816.

36. Boden, G. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. / G. Boden, X. Chen, J. L. Urbain // Diabetes. — 1996. — Vol. 45. — P. 1044­1050.

37. Bolli, G. B. Demonstration of a dawn phenomenon in normal human volunteers. / G. B. Bolli et al. // Diabetes. — 1984.— Vol. 33.— P. 1150­1153.

38. Borbely, A. A. Sleep Homeostasis and models of sleep regulation. In: Kryger, MH. Principles and Practice of Sleep Medicine. / A. A. Borbely, P. Achermann // Elsevier Saunders. Philadelphia, PA. — 2005. — P. 405-417.

39. Bode, B. W. Demonstrations and discussions of continuous glucose monitors./

B. W. Bode //Diabetes Technol. Ther.— 2005. — Vol.5. — P. 805-808.

40. Brabant, G. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. / G. Brabant et al. // Journal of Clinical Endocrinology and Metabolism. — 1990. — Vol. 70. — P. 403-409.

41. Buhr, E. D. Temperature as a universal resetting cue for mammalian circadian oscillators / E. D. Buhr, S. H. Yoo, J. S. Takahashi. // Science. — 2010. — Vol. 330, N 6002. — P. 379-385.

42. Buijs, R. M. Parasympathetic and sympathetic control of the pancreas: a role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake. / R. M. Buijs et al. // J. Comp. Neurol. — 2001. — Vol. 431, N 4. — P. 405-423.

43. Burgess, H. J. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg / H. J. Burgess et al. // J. Clin. Endocrinol. Metab. — 2010. — Vol. 95, N 7. — P. 3325-3331.

44. Buxton, O. M. Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase / O.M.Buxton et al.

45. Buxton, O. M. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. / O. M. Buxton et al. // Diabetes. — 2010. — Vol. 59, N 9. — P. 2126-2133.

46. Cabrera, C. The role of nitric oxide in the central control of blood pressure /

C. Cabrera, D. Bohr // Bioch. Biophys. Res. Commun. — 1995. — Vol. 26, N

I. — P. 77-81.

47. Cailotto, C. Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver / C. Cailotto, C. van Heijningen, J. Van Der Vliet // Endocrinology. — 2008. — Vol. 149. — P. 1914-1925.

48. Cain, S. W. Sex differences in phase angle of entrainment and melatonin amplitude in humans. / S. W. Cain et al. // Journal of Biological Rhythms. — 2010. — Vol. 25. — P. 288-296.

49. Campbell, P. J. Pathogenesis of the dawn phenomenon in patients with insulin­dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. / P.

J. Campbell et al. // N Engl J Med. — 1985. — Vol. 312. — P. 1473-1479.

50. Carroll, M. F. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy. / M. F. Carroll et al. // Diabetes Technol Ther. — 2002. — Vol. 4. — P. 595.

51. Carroll, M. F. The dawn phenomenon revisited: implications for diabetes therapy / M. F. Carroll, D. S. Schade // Endocr. Pract. — 2005. — Vol. 11, N 1. — P. 55-64.

52. Cassone, V. M. Effects of melatonin on vertebrate circadian systems / V. M. Cassone // Trends Neurosci. — 1990. — Vol. 13. — P. 457-464.

53. Castanon-Cervantes, O. Dysregulation of inflammatory responses by chronic circadian disruption. / O. Castanon-Cervantes et al // J Immunol. — 2010. — Vol. 185, N 10. — P. 5796-5805.

54. Cavalot, F. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study / F.

55. Ceriello, A. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. / A. Ceriello, S. Colagiuri // Diabet Med. — 2008. — Vol. 25. — P. 1151-1156.

56. Ceriello, A. Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer? / A. Ceriello // Diabetes Care. — 2009. — Vol. 32. — P. 521-522.

57. Ceriello, A. The glucose triad and its role in comprehensive glycaemic control: current status, future management / A. Ceriello // Int. J. Clin. Pract. — 2010. — Vol. 64, N 12. — P. 1705-1711.

58. Cernea, S. The incretin therapy at different stages of diabetes / S. Cernea // Rew. Diabet. Stud. — 2011. — Vol. 8, N 3. — P. 323-338.

59. Champaneri, S. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. / S. Champaneri et al. // Metabolism. — 2012. — Vol. 61, N 7. — P. 986-995.

60. Chiladakis, J. A. Autonomic effects of nebivolol versus atenolol in healthy subjects./ J.A. Chiladakis, E. Georgiopoulou, D. Alexopoulos // Cardiovasc. Drugs. Ther. — 2004. —Vol. 18, N 6. — P. 469-473.

61. Cobelli, C. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. / C. Cobelli et al. // Am. J. Physiol. Endocrinol. Metab. — 2007. — Vol. 293. — P. 1-15.

62. Christopher, J. The difficult decisions / J. Christopher et al. // Hypertension. —

2013. — Vol. 42, N 6. — P. 376-379.

63. Curione, М. Analysis of the chaotic component of the sinusal R-R intervals as a tool for detecting a silent cardiac dysautonomia in type 2 diabetes mellitus/ М. Curione et al. // Clin.Ter. — 2005. —Vol. 156, N 4. — P. 151-158.

64. Curtis, J. Preventing type 2 diabetes mellitus / J. Curtis // J. Am. Board Fam.Pract.— 2005. — Vol. 18, N 1. — P. 37-43.

65. Damiola, F. Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus / F. Damiola // Genes. Dev. 2000. — Vol.4, N 23. — P. 2950-2961.

66. Drazen, D. L. Effects of a Fixed Meal Pattern on Ghrelin Secretion: Evidence for a Learned Response Independent of Nutrient Status. / D. L. Drazen et al. // Endocrinology. — 2006. — Vol. 147. — P. 23-30.

67. Duttaroy, A. Muscarinic Stimulation of Pancreatic Insulin and Glucagon Release is Abolished in M3 Muscarinic Acetylcholine Receptor-Deficient Mice / A. Duttaroy et al. // Diabetes. 2004. —Vol. 53. — P. 1714-1720.

68. Eckel-Mahan, K. Metabolism and the circadian clock converge / K. Eckel- Mahan, P. Sassone-Corsi. // Physiol. Rev. — 2013. — Vol. 3, N 1. — P. 107­135.

69. Eguchi, Kazuo. Ambulatory blood pressure monitoring in diabetes and obesity - a review / Kazuo Eguchi // Int. J. Hypertens. —2011. —Vol. 2011. — P. 954757.

70. Dimitropoulos, G. Cardiac autonomic neuropathy in patients with diabetes mellitus./ G.Dimitropoulos, A.A.Tahrani, M.J. Stevens // World J. Diabetes.

2014. - Vol. 5, N 1 - P. 117-39.

71. Escobar, C. Peripheral oscillators: the driving force for food-anticipatory activity / C. Escobar et al. // Eur. J Neurosci. — 2009. — Vol.30, N 9. — P. 1665-1675.

72. Ewing, D. J. The natural history of diabetic autonomic neuropathy / D.J. Ewing et al. // Q. J. Med. —1980. — Vol. 49. — P. 95-108.

73. Rathmann, W. Mortality in diabetic patients with cardiovascular autonomic neuropathy. / W. Rathmann // Diabet Med. — 1993. — Vol. 10. — P. 820-824.

74. Ewing, D. J. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. / D.J. Ewing et al. // Br. Heart. J. — 1991. —Vol. 65. — P. 239-244.

75. Fabbian, F. Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms / F. Fabbian et al // Chronobiol. Int. —2013. —Vol. 30. —P. 17-30.

76. Feng, D. Clocks, metabolism, and the epigenome / D.Feng, M.A Lazar. // Mol. Cell. — 2012. — Vol. 47, N 2 — Р.158-67.

77. Fiorentini, A. Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients / A. Fiorentini // Cardiovasc. Diabetol. — 2005. — Vol. 1. — P. 4-15.

78. Fonken, L. K. Light at night increases body mass by shifting the time of food intake. / L. K. Fonken et al. // Proc. Natl. Acad. Sci. U S A. — 2010. — Vol. 107, N 43. — P. 18664-18669.

79. Frank, S. A. Effects of aging on glucose regulation during wakefulness and sleep / S. A. Frank et al. // Am. J. Physiol. — 1995. — Vol. 269, N 6. — P. 1006-1016.

80. Frieboes, R. M. Enhanced slow wave sleep in patients with prolactinoma. / R. M. Frieboes et al. // Journal of Clinical Endocrinology and Metabolism. — 1998. — Vol. 83. — P. 2706-2710.

81. Fry, M. The sensory circumventricular organs: Brain targets for circulating signals controlling ingestive behavior/ M. Fry, A. V. Ferguson // Physiology & Behavior. —2007 - Vol. 91. - P. 413-423.

82. Fullick, S. Prior exercise lowers blood pressure during simulated night-work with different meal schedules. / S. Fullick et al. // Am. J. Hypertens. — 2009. — Vol. 22, N 8. — P. 835-841.

83. Gale, J. E. Disruption of circadian rhythms accelerates development of diabetes through pancreatic beta-cell loss and dysfunction. / J. E. Gale J et al. // Biol Rhythms. — 2011. — Vol. 26, N 5. — P. 423-433.

84. Gamble, K. L. Circadian clock control of endocrine factors. / K. L. Gamble et al. // Nat. Rev. Endocrinol. — 2014. — Vol.10, N 8. — P. 466-475.

85. Garber, A. J. AACE comprehensive diabetes management algorithm 2013 / A.

J. Garber et al. //Endocr. Pract. — 2013. — Vol. 19, N 2. — P. 327-36.

86. Garliardino G. G. Circadian rhythm of urinary catecholamine excretion in healthy human / G. G. Garliardino, S. R. Hernandes, O. R. Rebolledo // Cronobiologia. — 1984. — Vol. 11. — P. 357-379.

87. Giugliano, D. Glucose metabolism and hyperglycemia. / D. Giugliano et al. // Am. J. Clin. Nutr. — 2008. — Vol. 87, N.1. — P. 217-222.

88. Gooley, J. J. Exposure to Room Light before Bedtime Suppresses Melatonin Onset and Shortens Melatonin Duration in Humans. / J. J. Gooley et al. // Journal of Clinical Endocrinology & Metabolism. — 2011. — Vol. 96. — P. 463-472.

89. Grossman, E. Melatonin reduces night blood pressure in patients with nocturnal hypertension. / E. Grossman et al. // Am. J. Med. — 2006. — Vol. 119, N 10. — P. 898-902.

90. Gupta, A. K. Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in

asymptomatic obese adults / A.K. Gupta // Cardiovasc. Diabetol. — 2010. — Vol. 9. — P. 58.

91. Hill, N. R. Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups / N. R. Hill, N. S. Oliver, P. Choudhary. // Diabetes Technology & Therapeutics. — 2011. — Vol. 13, N 9. — P. 921-928.

92. Hu, K. Endogenous circadian rhythm in vasovagal response to head-up tilt. / K. Hu et al. // Circulation. — 2011. — Vol. 123. — P. 961-970.

93. Humpert, P. M. Oxidative stress and glucose metabolism - is there a need to revisit effects of insulin treatment? / P.M. Humpert // Diabetologia. —2010. — Vol. 53, N 3 —P. 403-405.

94. Inchiostro, S. How can we monitor glycaemic variability in the clinical setting? / S. Inchiostro, F. Cavalot, R. Candido // Diabetes Obes. Metab. — 2013. — Suppl. 2. —P. 13-16.

95. John Service, F. Glucose variability / F. John Service // Diabet. — 2013. — Vol. 62, N 5. — P. 1398-1440.

96. Johnson, E. L. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications /E.L. Johnson // Adv. Exp. Med. Biol. — 2012. — Vol. 771. —P.139-154.

97. Jongen, C. Structural brain imaging in diabetes: a methodological perspective./

C. Jongen, G. J. Biessels // Eur. J. Pharmacol. — 2008. —Vol. 585. —P. 208­218.

98. Juutilainen, A. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects / A. Juutilainen, S. Lehto, T. Ronnemaa // Diabetes Care. — 2008. — Vol. 4. — P. 714-719.

99. Kalsbeek, A. Circadian control of the daily plasma glucose rhythm: an interplay of GABA and glutamate. / A. Kalsbeek et al. // PLoS. One. — 2008. — Vol. 3. — P. 3194.

100. Kalsbeek, A. Circadian disruption and SCN control of energy metabolism / A. Kalsbeek et al. // FEBS. Lett. — 2011. — Vol. 585, N 10. — P. 1412-1426.

101. Kalsbeek, A. Daily regulation of hormone profiles. / A. Kalsbeek, E. Fliers // Handb. Exp. Pharmacol. — 2013. — Vol. 217. — P. 185-226.

102. Kalsbeek, A. The hypothalamic clock and its control of glucose homeostasis. / A. Kalsbeek et al. // Trends Endocrinol Metab. — 2010. — Vol. 21, N 7. — P. 402-410.

103. Kalsbeek, A. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. / A. Kalsbeek et al. // Endocrinology. — 2001. — Vol. 142. — P. 2677-2685.

104. Kametani, H. Circadian rhythm of cortical acetylcholine release as measured by in vivo microdialysis in freely moving rats / H. Kametani, H. Kawamura // Neurosci. Lett. — 1991. — Vol. 132: —P. 263-266.

105. Kawachi, I. Prospective study of shift work and risk of coronary heart disease in women. / I. Kawachi et al. // Circulation. — 1995. — Vol. 92, N 11. — P. 3178-3182.

106. Ko, C. H. Molecular components of the mammalian circadian clock / C. H. Ko, J. S. Takahashi. // Human Molecular Genetics. — 2006. — Vol. 15. — Р. 271­277.

107. Kondo, K. Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in Type 2 diabetic patients / K. Kondo et al // Diabet. Med. —2002. —Vol. 19, N 5. — P. 359-365.

108. Konogaki, K: New insights to sympathetic regulation of glucose and fat metabolism. / K. Konogaki // Diabetologia. —2000. — Vol. 43. — P. 533-549

109. Kohsaka, A. Integration of metabolic and cardiovascular diurnal rhythms by circadian clock. / K. Kosaka et al // Endocr. J. — 2012. — Vol. 59, N 6. — P. 447-56.

110. Kreier, F. Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes. / F. Kreier et al. // Endocrinology. — 2006. — Vol. 147. — P. 1140-1147.

111. Kruszynska, Y. T. Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon./ Y.T Kruszynska, P. D. Home ∕∕ Diabete. Metab. — 1988.— Vol. 14.— P. 437-442.

112. La Fleur, S. E. Daily rhythms in glucose metabolism: suprachiasmatic nucleus output to peripheral tissue. / S. E. La Fleur // J. Neuroendocrinol. — 2003. — Vol. 15. — P. 315-322.

113. La Fleur, S. E. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. / S. E. La Fleur et al. // Brain Research. — 2000. — Vol. 71. — P. 50-56.

114. Lamia, K. A. Physiological significance of a peripheral tissue circadian clock. /

K. A. Lamia, K. F. Storch, C. J.Weitz // Proc Natl Acad Sci U S A. — 2008. — Vol. 105, N 39. — P. 15172-15177.

115. Landolt, H. P. Sleep homeostasis: a role for adenosine in humans? / H. P. Landolt // Biochem. Pharmacol. — 2008. — Vol. 75, N 11. — P. 2070-2079.

116. Lehto, S. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type 2 diabetes / S. Lehto et al. // Diabetologia. — 2000. — Vol. 43. — P. 148-155.

117. Linsell, C. R. Circadian rhythms of epinephrine and norepinephrine in man / C. R. Linsell // J. Clin. Endocrinology. — 1985. — Vol. 60. — P. 1210-1215.

118. Liu, C. Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. / C. Liu, M. U. Gillette. // J. Neurosci. — 1996. — Vol. 16. — P. 744-751.

119. Malliani, A. Cardiovascular neural regulation explored in the frequency domain / A. Malliani et al. // Circulation. —1991. —Vol. 84, N 2. —P. 482­492.

120. Malpas, S. C. Circadian variation of heart rate variability / S. C. Malpas // Cardiovasc. Res. — 1990. — Vol. 24, N 3. — P. 210-213.

121. Manschot, S.M. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients./ S.M. Manschot et al. // J. Neurol. Sci. — 2008 — Vol. 264. — P. 157-62.

122. Marcheva, B. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes / B. Marcheva et al. // Bass. J. Nature. —

2010. — Vol. 466, N 730. — P 627-631.

123. Martino, T. A. Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters. / T. A. Martino et al. // Am. J. Physiol. Regul. Integr. Comp. Physiol. — 2008. — Vol.294, N 5. — P. 1675­1683.

124. Mazze, R. S. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. / R. S. Mazze // Diabetes. Technol. Ther. — 2008. — Vol 10, N 3. — P.149-159.

125. Medendorp, W. P. Spatial constancy mechanisms in motor control / W. P. Medendorp //Philos. Trans. R. Soc. Lond. B. Biol. Sci. — 2011. — Vol. 366, N 1564. — P. 476-91.

126. Mendoza, J. Dimorphic effects of leptin on the circadian and hypocretinergic systems of mice. / J. Mendoza et al. // Journal of Neuroendocrinology. —

2011. — Vol. 23. — P. 28-38.

127. Merl, V. Preserved circadian rhythm of serum insulin concentration at low plasma glucose during fasting in lean and overweight humans. / V. Merl et al. // Metabolism. — 2004. — Vol. 53, N 11. — P. 1449-1453.

128. Monnier, L. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? / L. Monnier, C. Colette, D.R Owens // J. Diabetes Sci. Technol. —2008. Vol. 2, N 6. —P. 1094-1095.

129. Monnier, L. Contribution of postprandial glucose to chronic hyperglycaemia: from the «glucose triad» to the trilogy of «sevens» / L. Monnier, C. Colette, H. Boniface // Diabetes Metab. — 2006. — Vol. 32, N 2. — P. 6-11.

130. Monnier, L. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept / C. Colette ,

D. R. Owens // Diabetes Metabolism Research and Reviews. — 2009. — Vol. 25, N 5. — P. 393-402.

131. Monnier, L. Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? / L. Monnier // Eur J Clin Invest. — 2000. — Vol. 30, N 2. — P. 3-11.

132. Monnier, L. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? / L. Monnier, et al // Diabetes Care. — 2013. — Vol. 36, N 12. — P. 4057-4062.

133. Monnier, L. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. / L. Monnier et al. // Diabetes Care. — 2007. —Vol. 30, N 2. — P. 263-269.

134. Monnier, L. Frequency and severity of the dawn phenomenon in type 2 diabetes: relationship to age. / L. Monnier et al. // Diabetes Care. — 2012. — Vol. 35. — P. 2597-2599.

135. Montano, N. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt / N. Montano et al. // Circulation. —1994. —Vol. 90. — P. 1826-1831.

136. Moodithaya, S. Gender differences in age related changes in cardiac autonomic nervous function. / S. Moodithaya, ST. Avadhany // Journal of Aging Research. — 2012— P. 679345.

137. Morgan, L. Effects of the endogenous clock and sleep time on melatonin, insulin, glucose and lipid metabolism / L. Morgan et al. // Endocrinol. — 1998. — Vol.157, N 3. — P. 443-451.

138. Morris, C. J. Circadian system, sleep and endocrinology / C. J Morris, D. Aeschbach, F. A. Scheer. // Mol. Cell. Endocrinol. — 2012. — Vol. 349, N 1. — Р 91-104.

139. Morris, C. J. The impact of the circadian timing system on cardiovascular and metabolic function / C. J. Morris, J. N. Yang, F. A. Scheer // Prog. Brain. Res. — 2012. — Vol. 199. — P. 337-358.

140. Musen, G. Regional brain activation during hypoglycemia in type 1 diabetes. / G. Musen et al // J. Clin. Endocrinol. Metab. — 2008. — Vol. 93. — P. 1450­1457.

141. Nalysnyk, L. Glycaemic variability and complications in patients with diabetes mellitus:evidence from a systematic review of the literature. / L. Nalysnyk, M. Hernandez-Medina, G. Krishnarajah // Diabetes Obes. Metab. — 2010. — Vol. 12. — P. 288-298.

142. Natalucci, G. Spontaneous 24-h ghrelin secretion pattern in fasting subjects: maintenance of a meal-related pattern. / G. Natalucci et al. // European Journal of Endocrinology. — 2005. — Vol. 152. — P. 845-850.

143. National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics, 2011 // National Diabetes Information Clearinghouse.

2012. http://diabetes.niddk.nih.gov/dm/pubs/statistics.

144. Nerla, R. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients./ R. Nerla et al. // Heart. — 2012. —Vol. 98, N 24. — P. 1812-1816.

145. Niijima, A. Blood glucose levels modulate efferent activity in the vagal supply to the rat liver. / A. Niijima // J. Physiol. — 1985. — Vol. 364. — P. 105-112.

146. Nomura, K. Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c / K. Nomura et al. // ISRN Endocrinol. — 2011. — Vol. 2011, N 43. — P. 504.

147. Nonogaki, K. New insights into sympathetic regulation of glucose and fat metabolism. / K. Nonogaki //Diabetologia. — 2000. — Vol. 43, N 5. —P. 533-549.

148. Ohara, S. Untangling neural networks with dual retrograde transsynaptic viral infection / S. Ohara et al. // Front. Neurosci. — 2009. — Vol. 3. — P. 344-349.

149. Pavithran, P. Effect of antihypertensive drug therapy on short-term heart rate variability in newly diagnosed essential hypertension / P. Pavithran et al. // Clin. Exp. Pharmacol. Physiol. — 2010. — Vol. 37, N 2. — P. 107-113.

150. Perin, P. C. Sympathetic nervous system,diabetes, and hypertension / P. C. Perin, S. Maule, R. Quadri // Clin. Exp. Hypertens. — 2000. — Vol. 23. — P. 45-55.

151. Perreau-Lenz, S, Suprachiasmatic control of melatonin synthesis in rats: inhibitory and stimulatory mechanisms / S. Perreau-Lenz et al. // Eur. J. Neurosci. — 2003. — Vol. 17. — P. 221-228.

152. Perriello, G. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. / G. Perriello et al. // Diabetologia. — 1990. — Vol. 33. — P. 52-59.

153. Peter, R. Postprandial glycaemia and cardiovascular risk / R. Peter, A. Rees // Br. J. Diabetes Vasc. Dis. — 2008. — Vol. 8. — P. 8-14.

154. Pilcher, J. J. Effects of sleep deprivation on performance: a meta-analysis. / J. J. Pilcher, A. I. Huffcutt // Sleep. — 1996. — Vol. 19, N 4. — P. 318-326.

155. Pitocco, D. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues / D. Pitocco et al. // Minerva Endocrinol. — 2013. —Vol. 38, N 3. — P. 321-328.

156. Poanta, L.Blood pressure pattern and heart rate variability in normotensive patients with type 2 diabetes mellitus / L. Poanta, A. Cerghizan, D. Pop // Rom. J. Intern. Med. — 2010. —Vol. 48, N 4. — P. 321-327.

157. Pocai, A. A brain-liver circuit regulates glucose homeostasis. / A. Pocai et al. // Cell. Metab. — 2005. — Vol. 1. — P. 53-61.

158. Pocai, A. Hypothalamic K (ATP) channels control hepatic glucose production. / A. Pocai et al. // Nature. — 2005. — Vol. 434. — P. 1026-1031.

159. Porcellati, F. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. / F. Porcellati // Diabetes Care. —

2013. — Vol. 36, N 12. — P.3860-3862.

160. Portaluppi, F. The circadian organization of the cardiovascular system in health and disease / F. Porcellati // Indian. J. Exp. Biol. —2014. —Vol. 52. N 5. — P. 395-398.

161. Raz, I. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial / I. Raz, P. W. Wilson., K. Strojek // Diabetes Care. — 2009. — Vol. 32. — P. 381-86.

162. Reutrakul, S. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. / S. Reutrakul,

E. Van Cauter // Ann. N. Y. Acad. Sci. — 2014. — Vol. 1311. — P. 151-173.

163. Rodica, Pop-Busui. Cardiac Autonomic Neuropathy in Diabetes. A clinical perspective / Pop-Busui Rodica // Diabetes Care. — 2010. — Vol. 33. — P. 434-441.

164. Rodrιguez-Colon, S.M. Insulin resistance and circadian rhythm of cardiac autonomic modulation. / S.M. Rodriguez-Colon // Cardiovasc. Diabetol. — 2010. — Vol. 6, N 9. — P. 85.

165. Ruger, M. Effects of circadian disruption on the cardiometabolic system. / M. Ruger, F. A. Scheer // Rev. Endocr. Metab. Disord. — 2009. — Vol.10, N 4. — P. 245-260.

166. Saad, A. Diurnal pattern to insulin secretion and insulin action in healthy individuals / A. Saad et al. // Diabetes. — 2012. — Vol. 61, N 11. — P. 2691­2700.

167. Saper, C. B. Hypothalamic regulation of sleep and circadian rhythms. / C. B. Saper, T. E. Scammell, J. Lu // Nature. — 2005. — Vol. 437, N 7063. — P. 1257-1263.

168. Saydah, S. H. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes / S. H. Saydah, J. Fradkin,C. C. Cowie // JAMA. — 2004. — Vol. 291. — P.335-342.

169. Scheer, F. A. Adverse metabolic and cardiovascular consequences of circadian misalignment. / F. A. Scheer et al. // Proc. Natl. Acad. Sci. U S A. — 2009. — Vol. 106, N 11. — P. 4453-4458.

170. Scheer, F. A. Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditions. / F. A. Scheer et al. // Diabetologia. — 2010. — Vol. 53, N 11. — P. 2401-2405.

171. Scheer, F. A. Impact of the human circadian system, exercise, and their interaction on cardiovascular function. / F. A. Scheer et al. // Proc. Natl. Acad. Sci. USA. — 2010. — Vol. 107, N 47. — P. 20541-20546.

172. Scheer, F. A. Decreased sleep in heart failure: are medications to blame? / F. A. Scheer et al. // Archives of Internal Medicine. — 2007. —Vol. 167. — P. 1098-1099.

173. Schmidt, M. I. Fasting early morning rise in peripheral insulin: evidence of the dawn phenomenon in nondiabetes. ∕ M. I. Schmidt et al. // Diabetes Care — 1984.— Vol. 7. — P. 32-35.

174. Schmidt, M. I. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation. / M. I. Schmidt et al. // Diabetes Care. — 1981. — Vol. 4. — P. 579-585.

175. Schramm, T. K. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people / T. K. Schramm, Gislason, G. H. L. Kuber // Circulation. — 2008. — Vol. 117. — P. 1945-1954.

176. Senador, D. Cardiovascular and autonomic phenotype of db/db diabetic mice / D. Senador et al // Exp. Physiol. —2009. — Vol. 94, N 6. — P. 648-658.

177. Sergeeva, O.V. Effect of atropine, propranolol, and atenolol on wave structure of heart rate oscillations in rats./ O.V. Sergeeva, N.N. Alipov, V.M. Smirnov // Bull. Exp. Biol. Med. — 2008. — Vol. 145, N 4. — P. 387-390.

178. Sergeeva, O.V. Effect of adrenoblockers on slow (LF) waves in rabbit heart rate / O.V. Sergeeva, N.N. Alipov, V.M. Smirnov // Bull. Exp. Biol. Med. —

2014. — Vol. 157, N 3. — P. 295-298.

179. Shea, S. A. Independent circadian and sleep/wake regulation of adipokines and glucose in humans / S. A. Shea et al. // Clin. Endocrinol .Metab. — 2005. — Vol. 90, N 5. — P. 2537-2544.

180. Schmidt, M. I. The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation /M.I. Schmidt // Diabetes Care. —1981. — Vol.4. — P. 579-585.

181. Sheehan, J. P. Fasting hyperglycemia: etiology, diagnosis, and treatment. / J. P. Sheehan //Diabetes Technol. Ther. — 2004. — Vol. 6, N 4. — P. 525-533.

182. Singh, J.P. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). / J.P. Singh et al. // Am. J. Cardiol. — 2000. — Vol. 86, N 3. — P. 309-312.

183. Stenvers, D. J. What's the Time? Does the Artificial Pancreas Need to Know? / D. J Stenvers, J. H. DeVries, S. E. la Fleur //Diabetes. — 2013. — Vol. 62, N 7. — P. 2173-2174.

184. Stratton, I. M. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study/ I. M. Stratton, A. I. Adler, A. W. Neil // BMJ. — 2000. — Vol. 321. — P. 405-412.

185. Stuckey, M. I. Petrella R.J. Heart rate variability in type 2 diabetes mellitus./ M. I. Stuckey, R.J. Petrella // Crit. Rev. Biomed. Eng. — 2013. —Vol. 41, N 2. — Р.137-147.

186. Szabo, A. J. Vagotomy or atropine blocks hypoglycemic effect of insulin injected into ventromedial hypothalamic nucleus. / A. J. Szabo et al. // Am. J. Physiol. — 1983. — Vol. 244. — P. 467-471.

187. Tamura, K. A possible relationship of nocturnal blood pressure variability with coronary artery disease in diabetic nephropathy / K. Tamura et al. // Clin. Exp. Hypertens. —2007. — Vol. 1. — P. 31-42.

188. Tesfaye, S. Vascular risk factors and diabetic neuropathy / S. Tesfaye // N. Engl. J. Med. — 2005. — Vol. 352. — P. 341-350.

189. The NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events // N. Engl. J. Med. — 2010. — Vol. 362. — P. 1463-1476.

190. Turek, F. W. Obesity and metabolic syndrome in circadian Clock mutant mice / F. W. Turek et al. // Science. — 2005. — Vol. 308, N 5724. — P. 1043-1045

191. Umpierrez, G. E. Use of incretin-based therapy in hospitalized patients with hyperglycemia. / G. E. Umpierrez S. Schwartz // Endocr. Pract. — 2014. — Vol. 20, N 9. — P. 933-944.

192. Van Cauter, E. Endocrine Physiology. In: Kryger. Principles and Practice of Sleep Medicine / E. Van Cauter // Elsevier Saunders Philadelphia. — 2005. — Vol. 99, N 5. — P. 266-282.

193. Van Cauter, E. Roles of circadian rhythmicity and sleep in human glucose regulation. / E. Van Cauter, K. S. Polonsky, A. J.Scheen // Endocr. Rev. — 1997. — Vol. 18, N 5. — P. 716-738.

194. Van Den Heuvel, C. J. Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin. / C. J. Van Den Heuvel, K.J. Reid, D. Dawson // Physiol. Behav. — 1997. — Vol. 61, N 6. — P. 795-802.

195. Van Den Hoek, В. Intracerebroventricular administration of NPY hampers insulin action to suppress endogenous glucose production via the sympathetic nervous system / B. Van Den Hoek et al. // Diabetes. — 2008. — Vol. 57. — P. 2304-2310.

196. Van Harten, B. Brain imaging in patients with diabetes: a systematic review./ B. Van Harten et al. // Diabetes Care. — 2006. — Vol. 29. — P. 2539-2548.

197. Vantyghem, M. C. Treating diabetes with islet transplantation: Lessons from the past decade in Lille / M. C. Vantyghem et al. // Diabetes Metab. — 2014. — Vol. 40, N 2. — P. 108-109.

198. Vidarsdottir, S.Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes / S. Vidarsdottir et al. // Diabetes. — 2007. — Vol. 56. — P. 2547-2550.

199. Vinik, A. I. Diabetic Autonomic Neuropathy / A. I.Vinik et al. // Diabetes Care. — 2003. — Vol. 26. — P. 1553-1579.

200. Wehr, T. A. Evidence for a biological dawn and dusk in the human circadian timing system. / T. A. Wehr, D. Aeschbach ,W. C. Jr. Duncan // J. Physiol. — 2001. — Vol. 535, N 3. — P. 937-951.

201. Wei, M. Effect of diabetes and level of glycemia on all-cause and cardiovascular mortality. The Sun Antonio Heart Study / M. Wei, S. Gaskill, S. Haffner // Diabetes Car. — 1998. — Vol. 21. — P. 1167-1172

202. Wojaczynski, G. J. The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties [Epub. ahead of print] / G. J. Wojaczynski // Brain Struct Funct. — 2014.

203. Yano, Y. Nighttime blood pressure, nighttime glucose values, and target-organ damages in treated type 2 diabetes patients / Y. Yano // Atherosclerosis. — 2013. — Vol. 227, N 1. — P. 135-139.

204. Yi, C. X. A major role for perifornical orexin neurons in the control of glucose metabolism in rats / C. X. Yi, M. J. Serlie, M. T. Ackermans // Diabetes. — 2009. — Vol. 58. — P.1998-1920.

205. Yi, C. X. Pituitary adenylate cyclase-activating polypeptide stimulates glucose production through glycogenolysis and via the hepatic sympathetic innervation in rats / C. X. Yi, N. Sun, M. T. Ackermans. // Diabetes. — 2010. — Vol. 59. — P. 1591-1600.

206. Yoo, S. H. PERIOD2: LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues / S. H. Yoo et al. // Proc. Natl. Acad. Sci. U S A. — 2004. — Vol. 15 — Р. 5339-5346.

207. Zaccardi, F. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability / F. Zaccardi // Diabetes Metab. Res. Rev. — 2009. — Vol. 29. — Р. 199-207.

208. Zeitzer, J. M. Circadian and homeostatic regulation of hypocretin in a primate model: Implications for the consolidation of wakefulness. / J. M. Zeitzer et al. // J. Neurosci. — 2003. — Vol. 23. — P. 3555-3560.

209. Zenari, L. What are the preferred strategies for control of glycaemic variability in patients with type 2 diabetes mellitus? / L. Zenari, A. Maranon // Diabetes Obes. Metab. — 2013. — Suppl. 2. — P. 17-25.

210. Zhang, S. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. / S. Zhang et al. // Sleep. — 2004. — Vol. 27. — P. 619­627.

211. Zhao, R. Influences of Age, Gender, and Circadian Rhythm on Deceleration Capacity in Subjects without Evident Heart Diseases./ R. Zhao et al. // Ann Noninvasive Electrocardiol. — 2014. — Vol. 10.1111. — P. 12189.

212. Zhou, W. J. A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension. / W. J. Zhou et al. // PLoS One. — 2013. — Vol. 10, N 8. — P. 72102.

213. Zhou, J. Reference values for continuous glucose monitoring in Chinese subjects / J. Zhou et al. // Diabetes Care. — 2009. — Vol. 32, N 7. — P. 1188­1193.

214. Ziegler, D. Management of painful diabetic neuropathy: what is new or in the pipeline for 2007? / D. Ziegler //Diabetologia. — 2007. — Vol. 50. — P. 63.

215. Ziegler, D. Epidemiology of polyneuropathy in diabetes and prediabetes./ D. Ziegler // Handb. Clin. Neurol. — 2014. — Vol. 126. — P. 3-22.

216. Zulfiqar,U. Relation of high heart rate variability to healthy longevity / U. Zulfiqar et al. // The American journal of cardiology. — 2010. Vol. 105.8. — P. 1181-1185.